𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II study of alpha-interferon and 13-cis-retinoic acid in metastatic melanoma

✍ Scribed by Kapil Dhingra; Nicholas Papadopoulos; Scott Lippman; Reuben Lotan; Sewa S. Legha


Publisher
Springer US
Year
1993
Tongue
English
Weight
336 KB
Volume
11
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A Phase II pilot trial of 13-cis retinoi
✍ Felix H. Brembeck; Klaus Schoppmeyer; Ursula Leupold; Costel Gornistu; Volker Ke πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 87 KB πŸ‘ 1 views

## BACKGROUND. Advanced unresectable pancreatic adenocarcinoma has a dismal prognosis. The authors previously have shown that retinoic acid (RA) and interferon-␣ (IFN-␣) inhibit growth and induce differentiation in human pancreatic carcinoma cells in vitro and in vivo. The purpose of this trial wa

Phase II clinical trial of 13-cis-retino
✍ Peter C. Enzinger; David H. Ilson; Leonard B. Saltz; Lisa K. Martin; David P. Ke πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 68 KB πŸ‘ 1 views

## BACKGROUND. Interferon in combination with 5-fluorouracil has been shown to be active in squamous cell carcinoma (SCC) and adenocarcinoma (AC) of the esophagus. 13-cis-retinoic acid (CRA) has chemopreventive activity in SCC of the head and neck, and, in combination with interferon, has antitumo